Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Dr. Agarwal's Health Care Limited (NSE: AGARWALEYE), ISIN INE943P01029 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
AGARWALEYE last traded at ₹536.20 (+3.84%), with a 52-week range of ₹401.00 to ₹567.75 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 32.33%, FIIs 49.56%, DIIs 15.86%, mutual funds 14.18%.
EquiSense Score (ECS): 75/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.